Hypophosphatemia: Clinical Trials

95 trials for Hypophosphatemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed, 17 unknown, 9 recruiting, 6 active not recruiting. 13 Not applicable, 12 Phase 2, 12 Phase 3, 11 Phase 1, 8 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable13Completed 7, Not yet recruiting 2, Recruiting 2, Terminated 1, Withdrawn 1
Phase 212Completed 7, Recruiting 3, Terminated 1, Unknown 1
Phase 312Completed 11, Unknown 1
Phase 111Completed 7, Terminated 2, Recruiting 1, Unknown 1
Phase 48Completed 4, Unknown 4
Early Phase 13Completed 2, Recruiting 1

Follow Hypophosphatemia: new trials by email Literature Review of Hypophosphatemia trials Research Report on Hypophosphatemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Respiratory Quotient and Phosphate Changes During Early Critical Illness
Nutritional Exposure During Early Critical Illness - Refeeding Syndrome, Critical Illness
Not yet recruitingVastra Gotaland Region402026-11-012026-09-02
Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical Diagnosis
intra-oral 3D optical impression - Osteogenesis Imperfecta, Rare Bone Disorders
Not applicableNot yet recruitingUniversity Hospital, Bordeaux2402026-09-012026-06-24
Phosphate in Acute Pancreatitis
Sodium Phosphate, Potassium Phosphate - Pancreatitis
Phase 2RecruitingDuke University1002026-07-092026-08-26
Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia
No treatment given - X-linked Hypophosphatemia (XLH)
WithdrawnNovo Nordisk A/S2026-07-072026-08-28
Protocolised Management of Phosphate Replacement Trial
Liberal Phosphate Replacement Protocol, Restrictive Phosphate Replacement Protocol - Phosphate Deficiency, Hypophosphatemia
Not applicableNot yet recruitingCaboolture Hospital24002026-01-012025-12-17
Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia.
Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules - Hypophosphatemia
Not applicableRecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology602025-11-212025-11-28
Effective Dosing of Burosumab in XLH
X-linked Hypophosphatemia (XLH)
RecruitingUniversity of Nottingham1202025-11-032026-05-11
Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism
Phosphate Deficiency, Phosphate Overload
Not yet recruitingF.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore1002025-06-012025-02-14
Phosphorus-31 Spectroscopy in Phosphate Diabetes
intra-muscular ATP values in phosphate diabetes, intra-muscular phosphate values in phosphate diabetes - Phosphate Diabetes, X-linked Hypophosphatemia
Not applicableRecruitingHospices Civils de Lyon652025-05-162026-07-23
Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients
Dipyridamole 75 MG - Hypophosphatemia, Kidney Transplantation
Phase 2RecruitingStanford University902025-05-152026-06-11
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
KK8123 - X-linked Hypophosphatemia
Phase 1 / Phase 2RecruitingKyowa Kirin Co., Ltd.392024-10-092026-09-21
Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator Weaning
Sodium Glycerophosphate 216 MG/ML - Mechanical Ventilation, Weaning Failure
RecruitingPeking Union Medical College702024-10-012025-05-31
IV Iron-induced Hypophosphatemia After RYGB
Iron isomaltoside, Iron Carboxymaltose - Hypophosphatemia, Roux-en-Y Gastric Bypass
Phase 4UnknownLucie Favre942024-05-022024-08-20
Metabolic Pathway Analysis in Intensive Care Unit Patients With Refeeding Syndrome
Metabolomics - Critical Illness, Refeeding Syndrome
CompletedKarolinska University Hospital2182024-04-012025-04-02
Effect of Burosumab on the Inflammatory Profile of Patients With X-linked Hypophosphatemic Rickets FLAM-XLH
Expression of inflammatory markers (Il6, Il8, Il1β, CXCL1, CCL2, CXCR3, Il1R, Il6R) - X-Linked Hypophosphatemic Rickets
UnknownHospices Civils de Lyon202024-04-012024-03-06
Validation of the GIDS and Description of Phosphate Disorders
Gastrointestinal Dysfunction Score will be calculated - Organ Dysfunction Scores, Hypophosphatemia
CompletedUniversity of Tartu26812024-01-082025-03-25
Phosphate Urine Excretion in Critically Ill Patients
Critically Ill Intensive Care Unit Patients
Active not recruitingRabin Medical Center2052023-09-112025-05-28
Risk Factors for Refeeding Syndrome in the Surgical Intensive Care Unit
Refeeding Syndrome - Refeeding Syndrome
UnknownSamsun University602023-06-092023-09-26
Anergia-anhedonia by Lithium-induced Phosphorus Diabetes
Mood Disorders
UnknownUniversity Hospital, Strasbourg, France602023-05-012023-11-01
Effects of Treatments for Anemia and Iron Deficiency on the Electrolyte Balance in Lung Transplant Recipients: A Special Focus on Hypophosphatemia
no intervention - Hypophosphatemia
Active not recruitingUniversity of Zurich2502023-02-172023-11-01

Showing 20 of 95. Sign in to see all of them.

Narrower conditions

Familial Hypophosphatemic Rickets (49)  ·  Rickets, Hypophosphatemic (9)  ·  Rickets (7)  ·  Hypophosphatemia, Familial (6)  ·  Refeeding Syndrome (6)  ·  Hyperparathyroidism (5)  ·  Osteomalacia (5)  ·  Hyperphosphatemia (4)  ·  Oncogenic osteomalacia (4)  ·  Renal Insufficiency, Chronic (4)  ·  Anemia, Iron-Deficiency (3)  ·  Iron Deficiencies (3)  ·  3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (2)  ·  Acidemia, isovaleric (2)

Broader conditions

Nutritional and Metabolic Diseases (95)  ·  Phosphorus Metabolism Disorders (95)  ·  Metabolic Diseases (94)  ·  Nutrition Disorders (64)  ·  Malnutrition (63)  ·  Female Urogenital Diseases and Pregnancy Complications (60)  ·  Urogenital Diseases (60)  ·  Calcium Metabolism Disorders (59)  ·  Female Urogenital Diseases (59)  ·  Male Urogenital Diseases (59)  ·  Urologic Diseases (59)  ·  Avitaminosis (58)  ·  Deficiency Diseases (58)  ·  Musculoskeletal Diseases (58)  ·  Vitamin D Deficiency (58)

Interventions

burosumab (21)  ·  Cinacalcet (4)  ·  Phosphates (3)  ·  ferric carboxymaltose (3)  ·  iron isomaltoside 1000 (3)  ·  Calcitriol (2)  ·  alpha-glycerophosphoric acid (2)  ·  ferric derisomaltose (2)  ·  potassium phosphate (2)  ·  sodium phosphate (2)  ·  1,25-dihydroxyvitamin D (1)  ·  Anti-Bacterial Agents (1)  ·  Blood Specimen Collection (1)  ·  Calcitonin (1)  ·  Caseins (1)

Sponsors

Kyowa Kirin Co., Ltd. (10)  ·  Kyowa Kirin, Inc. (6)  ·  Hospices Civils de Lyon (5)  ·  Kyowa Kirin Pharmaceutical Development Ltd (5)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (4)  ·  Yale University (4)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Bicetre Hospital (2)  ·  Children's Mercy Hospital Kansas City (2)  ·  Indiana University (2)  ·  Pharmacosmos A/S (2)  ·  University Hospital, Brest (2)  ·  University Hospital, Strasbourg, France (2)  ·  University of Aarhus (2)  ·  Wuerzburg University Hospital (2)

Countries

United States (35)  ·  France (21)  ·  United Kingdom (13)  ·  Germany (9)  ·  Italy (9)  ·  Canada (8)  ·  Japan (7)  ·  Switzerland (6)  ·  China (5)  ·  Denmark (5)  ·  Netherlands (5)  ·  Spain (5)  ·  South Korea (4)  ·  Sweden (4)  ·  Australia (3)

Top investigators

Amy Zhang, PhD (2)  ·  Rachel I Gafni, M.D. (2)  ·  Ahmed Kamal, Dr. (1)  ·  Alex Mullen (1)  ·  Andrew M South, MD MS (1)  ·  Arthur van Zanten, PhD (1)  ·  Brona Roberts (1)  ·  Carel W Le Roux, MRCPath, MRCP, PhD (1)  ·  Clemens Bergwitz, MD (1)  ·  Curt Scharfe, MD, PhD (1)  ·  Dieter Haffner, MD (1)

Results publications

PMID 39151033, PMID 32721016, PMID 40962182, PMID 25919461, PMID 32016310, PMID 36854566, PMID 10231464, PMID 11260415, PMID 11334065, PMID 11422774, PMID 12373466, PMID 12376810, PMID 12608553, PMID 12761615, PMID 14600809, PMID 14750100, PMID 15256798, PMID 15296888, PMID 15855212, PMID 16453140, PMID 16696865, PMID 16698131, PMID 16879061, PMID 16932387, PMID 17060000, PMID 17071958, PMID 17342691, PMID 17507907, PMID 17699189, PMID 18402655, PMID 18432588, PMID 18492867, PMID 18820097, PMID 18843706, PMID 19089795, PMID 19114912, PMID 19255959, PMID 19426417, PMID 20093826, PMID 20480135, PMID 20586025, PMID 20682049, PMID 20876598, PMID 21075821, PMID 21106112, PMID 21183586, PMID 21345279, PMID 21382993, PMID 21385861, PMID 21517979

NIH funding

1UL1TR001863-01 (1), 2014 (1), P50AR054086 (1), R01DK142980 (1), R21AR061818 (1)